Rethinking ovarian cancer: recommendations for improving outcomesSebastian Vaughan, Frances R. Balkwill, Douglas A. Levine et al.|Nature reviews. Cancer|2011Cited by 1.5k
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G.W. Verhaak, Matthew Meyerson, Pablo Tamayo et al.|Journal of Clinical Investigation|2012Cited by 591
Synthetic lethality between <i>CCNE1</i> amplification and loss of <i>BRCA1</i>Dariush Etemadmoghadam, David D.L. Bowtell, Barbara A. Weir et al.|Proceedings of the National Academy of Sciences|2013Cited by 227
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian CancersÅslaug Helland, David D.L. Bowtell, Joshy George et al.|PLoS ONE|2011Cited by 219
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment OutcomeZhigang C. Wang, Nicolai J. Birkbak, Aedín C. Culhane et al.|Clinical Cancer Research|2012Cited by 162